CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Scadden David Director | Grant or award · Stock Option (right to buy) | +51,700 | 51,700 | ||
| 2025-06-06 | Scadden David Director | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2024-05-30 | Scadden David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-01 | Scadden David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Scadden David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-03 | Scadden David Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2020-06-10 | Scadden David Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2019-02-05 | Scadden David Director | Grant or award · Stock Option (right to buy) | +23,076 | 23,076 |
Page 1 of 1 · 8 trades